Flexipak
Product Images NDC 69336-202

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Flexipak (NDC 69336-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sterling-knight Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Caps (Capsaicin Cream 60g)

Caps (Capsaicin Cream 60g)
This is a drug information label for Capsaicin Cream, 0.025%, an external analgesic used for penetrating pain relief. The cream comes in a 2.1 oz (60 g) tube and is made by Rugby Laboratories, Inc. The active ingredient is Capsaion 0026%. The label includes directions for use, warnings about possible sensations and what to do in case of an adverse reaction, a list of inactive ingredients, and a phone number for questions or comments.*
FDA Label Image

Disod (Disod)

FDA Label Image

Flexipak (Flexipak Box)

Flexipak (Flexipak Box)
This appears to be a list of pharmaceutical products, including Flexipak, diclofenac sodium tablets, and capsaicin cream. The label "RxOnly" suggests that these items are only available by prescription.*
FDA Label Image

Im1 (Im1)

FDA Label Image

Im2 (Im2)

FDA Label Image

Im3 (Im3)

FDA Label Image

Tab1 (Tab1)

Tab1 (Tab1)
This text suggests that certain factors such as increasing doses of NSAIDs, longer use of NSAIDs, smoking, drinking alcohol, older age, poor health, advanced liver disease, and bleeding problems may contribute to health issues or complications. These factors should be considered and monitored closely to ensure the best possible health outcomes.*
FDA Label Image

Tab2 (Tab2)

Tab2 (Tab2)
This text appears to be describing symptoms that someone may experience during a medical emergency. The symptoms include: shortness of breath, slurred speech, trouble breathing, chest pain, swelling of the face or throat, and weakness in one part or side of the body. These symptoms can indicate a variety of different medical conditions, but they generally require urgent medical attention.*
FDA Label Image

Tab3 (Tab3)

FDA Label Image

Table1 (Table1)

Table1 (Table1)
Table 1 shows pharmacokinetic parameters for Diclofenac in normal healthy adults aged 20-48 years. The table includes coefficient of variation, mean absolute bioavailability, oral clearance, renal clearance, apparent volume of distribution and terminal half-life.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.